As yesterday saw the first debut of a SPAC IPO in nearly two weeks, Heroic Empire Acquisition Limited also broke the silence on the new filings front. More
This week, we speak with Michael Beer, CFO of Agility Robotics, and Daniel Diez, Chief Business Officer of the company. Together, we discuss Agility’s $2.5 billion business combination with Churchill Capital Corp. More
Heroic Empire has filed for a $100 million IPO in what is the first new SPAC S-1 to hit the SEC in two weeks. Well, "new" is perhaps a misnomer in this case, as the team previously filed to IPO a SPAC under the same name back in 2022. More
SPACCircle Acquisition Corp. (NASDAQ:SCQCU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol "SCQCU" on Tuesday, October 27, 2026. More
Amanat (NASDAQ:AMAN) has entered into a definitive agreement to combine with biotech firm Corxel Pharmaceuticals at an enterprise value of $228 million. Corxel is developing an oral GLP-1 weight-loss drug as well as other potential treatments. More
With just one week left in October, the month has currently represented a slowdown in SPAC IPOs, with just four teams pricing their vehicles since October 1. More
Terms Tracker for the Week Ending October 23, 2026 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week's pricings. It was a very quiet week with zero SPAC IPOs priced and zero new SPACs filed, but there were two new deals announced to bring the year-to-date announcement count to 85. More
APEX Tech (NYSE:TRAD) has entered into a definitive agreement to combine with South Korean film studio Korai Flix at a $3.5 billion pre-money equity value. Korai Flix has launched an online content platform that provides AI-generated short films and allows users to produce their own interactive content with AI avatars. More
This week, we speak with Andrew Clare, CEO of Elroy Air, which announced a $961 million business combination with Inflection Point Acquisition Corp. VII (NASDAQ:IPXG) in June. Drones are suddenly everywhere, but very few can handle jobs that require heavy lift along with vertical takeoff. More
TCGX I (NASDAQ:TCGX) has signed a definitive agreement to combine with drug developer TriGemX Bio at a pro forma enterprise value of $402.8 million. New York-based TriGemX Bio is developing a drug candidate for the treatment of acute migraines that is currently in Phase III trials. More